By HotStockRockets | Tuesday 13 September 2016
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
The good news is that a 1.5 million share overhang in Optibiotix (OPTI) has now been cleared. So the shares should soar on good news. The bad news is that we have to wait a bit longer for that good news... Instead we get an RNS that was never going to set the share price on fire. Optibiotix has announced the results of a survey of customers of its GoFigure slimming shakes and bars. 30 lard buckets took part in the survey.
As such this cannot be seen as a truly scientific study. Having said all of that the results appear good. The data is
1. 100% of customers who used the products over a continued period lost weight (average 1.2kg weight loss per week, based on average reduction of 7-9 lbs over three weeks)
2. 100% of customers reported that using GoFigure® products led them to reduce food intake (typically by eating smaller food portions)
3. 93% of customers reported that using GoFigure products had led to reduced snacking
4. 83% of customers reported they felt less hungry when using the product
The cynics will say that since only 24% of those who had bought direct from the GoFigure website took part you are likely to have only the happiest punters playing ball. So while the data looks good you can understand why the shares did not race ahead on it - they are now 71p-72p.
What we all want is news of the demerger of one of Optibiotix's four divisions. That should drive a material re-rating. It is a pain waiting but wait we do as that re-rate will be big and the news should noit be that long in coming. The shares are a buy at up to 80p with a target to sell of 100p+
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments are turned off for this article.
Search ShareProphets |
Stock market news |
Recent Comments |